A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder. Kim S-H, Huh S-Y, Lee S J, Joung A, Kim H J JAMA Neurol. 2013 Jul 29. PMID: 23897062. Abstract CommentRecommendBookmarkWatch